Home›Stock Screener›Gland Pharma›Quarterly Results

Gland Pharma Quarterly Results

Latest Quarter Net Profit
₹291 Cr
QSept 2026
Quarterly Results

Gland Pharma quarterly results. In Sept 2026, Gland Pharma (GLAND) reported revenue ₹1,903 Cr and net profit ₹291 Cr — revenue +21.1% YoY. For annual financials, live price and key ratios, visit GLAND share price.

GLAND Quarterly Results — Revenue, Profit & EPS Highlights

Gland Pharma latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore GLAND price movement history to track price trends across different timeframes.

  • Revenue of ₹1,903 Cr in Sept 2026 (+2.6% vs Mar 2026, +21.1% vs Sept 2025)
  • Net Profit of ₹291 Cr in Sept 2026 (-20.7% vs Mar 2026, +58.2% vs Sept 2025)
  • EBITDA of ₹553 Cr in Sept 2026 (-11.5% vs Mar 2026)
  • Operating Margin of 26.0% in Sept 2026 (-3.0pp vs Mar 2026)
  • Earnings Per Share of ₹17.62 in Sept 2026 (-20.8% vs Mar 2026)

Gland Pharma Quarterly Results — Revenue, EBITDA, Net Profit & EPS

GLAND quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 QoQ YoY
Revenue (₹ Cr) 1,903 1,854 1,862 1,571 1,469 2.6% 21.1%
Net Profit (₹ Cr) 291 367 317 184 187 - -
EBITDA (₹ Cr) 553 625 551 398 392 - -
EPS (₹) 17.62 22.26 19.23 11.15 11.32 - -
Operating Margin (%) 26.0% 29.0% 27.0% 21.0% 24.0% - -

GLAND Share Price Trend — 1-Year Movement Across Quarterly Results

Gland Pharma 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. View Gland Pharma 52-week for the annual high/low range and current price position.

Profitability Ratios

Profit Margin 15.3%
EBITDA Margin 29.1%
Operating Margin 26.0%
ROE (Annual) 11.2%

Balance Sheet Highlights

Total Assets ₹12,511 Cr
Total Equity ₹10,358 Cr
Current Assets ₹ Cr
Current Liabilities ₹545 Cr

Cash Flow Analysis

Operating Cash Flow ₹1,031 Cr
Investing Cash Flow ₹189 Cr
Financing Cash Flow ₹-417 Cr
Net Cash Flow ₹803 Cr

Current Market Data

Current Price ₹3292.90
Exchange NSE
Last Updated Nov 19, 2026

GLAND vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Gland Pharma latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1900.0 16,617 1,995 +10.6% - 12.0% 228.9
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11178.0 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4611.0 4,111 364 +27.7% +42.2% 8.9% 400.6
Apollo Hospitals
Sept 2026
₹126,832.45 Cr 8738.0 7,673 660 +15.2% - 8.6% 199.4
Laurus Labs
Sept 2026
₹125,946.78 Cr 2306.0 2,219 436 +21.7% - 19.6% 282.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores